Prestige Consumer Healthcare (PBH) officer reports stock sales in Form 4 filing

Rhea-AI Filing Summary

Prestige Consumer Healthcare Inc. officer Jeffrey Zerillo, Senior VP Operations, reported two open-market sales of company stock. On 11/28/2025, he sold 719 shares of common stock at $60 per share, leaving him with 42,329 shares beneficially owned afterward. On 12/01/2025, he sold an additional 281 shares at $60 per share, reducing his holdings to 42,048 shares.

The filing is a Form 4, which discloses changes in ownership by company insiders and confirms that Zerillo’s holdings remain directly owned after these transactions.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Zerillo Jeffrey

(Last) (First) (Middle)

660 WHITE PLAINS ROAD

(Street)

TARRYTOWN NY 10591

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Prestige Consumer Healthcare Inc. [ PBH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Senior VP Operations

3. Date of Earliest Transaction (Month/Day/Year)
11/28/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, par value $0.01 per share	11/28/2025		S		719	D	$60	42,329	D
Common Stock, par value $0.01 per share	12/01/2025		S		281	D	$60	42,048	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Jeffrey Zerillo by William P'Pool as attorney-in-fact pursuant to power of attorney dated August 7, 2018 on file with the Commission	12/02/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Prestige Consumer Healthcare (PBH) report in this Form 4?

The Form 4 reports that Jeffrey Zerillo, Senior VP Operations of Prestige Consumer Healthcare Inc., sold shares of the company’s common stock in two separate transactions.

How many PBH shares did the insider sell and at what prices?

On 11/28/2025, Jeffrey Zerillo sold 719 shares of common stock at $60 per share. On 12/01/2025, he sold another 281 shares at $60 per share.

How many Prestige Consumer Healthcare (PBH) shares does the insider own after these transactions?

After the 11/28/2025 sale, Zerillo beneficially owned 42,329 shares. Following the 12/01/2025 sale, his beneficial ownership was 42,048 shares, held directly.

What is the role of the reporting person in Prestige Consumer Healthcare (PBH)?

The reporting person, Jeffrey Zerillo, is identified as an Officer of Prestige Consumer Healthcare Inc., with the title Senior VP Operations.

Does this Form 4 for PBH include any derivative securities transactions?

The section for derivative securities (Table II) is present but does not list any derivative securities acquired, disposed of, or beneficially owned in the reported period.

Is the PBH Form 4 filed by one or multiple reporting persons?

The filing is indicated as a Form filed by One Reporting Person, referring to Jeffrey Zerillo.